21 CFR Part 814 Premarket Approval
Navigate 21 CFR Part 814 with expert PMA consulting built for Class III medical devices. Elexes helps manufacturers strengthen strategy, technical documentation, clinical evidence alignment, and FDA responses so submissions are review-ready, defensible, and less likely to stall in costly deficiency cycles.
Our Premarket Approval Services
Focused PMA support for strategy, readiness, documentation, and FDA interaction management.
PMA Submission
End-to-end support for FDA Premarket Approval submissions for Class III devices, including PMA basics, supplements, amendments, quality system support, and submission management.
Readiness Assessment
Structured evaluation of device, evidence, risk files, and quality documentation against submission expectations to identify gaps before filing and reduce avoidable review delays.
Pre-Submission Support
Preparation for FDA interactions through pathway planning, mock meetings, regulatory strategy development, and early issue identification before formal PMA submission.
Agency Responses
Expert support for responding to FDA actions, inquiries, and additional information requests with clear, organized, and defensible submissions.
Change Assessment
Documented evaluation of design, labeling, software, or manufacturing changes to determine whether PMA supplements or other regulatory actions are required.
RMF/DHF Remediation
Focused remediation of risk management and design history files to improve traceability, submission credibility, and audit defensibility for PMA programs.
FDA Submission Support
Build a Stronger PMA Submission
21 CFR Part 814 demands more than assembling documents. Elexes helps manufacturers build a PMA strategy that aligns clinical evidence, technical documentation, risk management, and quality system records into a coherent submission. Our team works to reduce preventable deficiencies, strengthen FDA-facing responses, and keep high-stakes Class III device approvals moving with greater clarity and control.
Trusted By Manufacturers
Success Stories
See how manufacturers rely on Elexes for complex regulatory submissions and compliance support.
“Kudos to the Elexes team! They’re always proactive and have provided invaluable support to us with import, labels, and registrations.”
Philip McFerran
“Having Elexes as our import-export expert was a great choice. Elexes’ team answered all our questions and guided us through every step.”
Linda Pan
“Highly recommend Elexes! They always meet commitments and follow through on action items.”
Joshua Mink
“Highly recommended! They excelled at regulatory projects, and document control, and grasped our product’s nuances quickly.”
Michal Depa
“Kudos to the Elexes team! They’re always proactive and have provided invaluable support to us with import, labels, and registrations.”
Philip McFerran
“Having Elexes as our import-export expert was a great choice. Elexes’ team answered all our questions and guided us through every step.”
Linda Pan
“Highly recommend Elexes! They always meet commitments and follow through on action items.”
Joshua Mink
“Highly recommended! They excelled at regulatory projects, and document control, and grasped our product’s nuances quickly.”
Michal Depa
“Kudos to the Elexes team! They’re always proactive and have provided invaluable support to us with import, labels, and registrations.”
Philip McFerran
“Having Elexes as our import-export expert was a great choice. Elexes’ team answered all our questions and guided us through every step.”
Linda Pan
“Highly recommend Elexes! They always meet commitments and follow through on action items.”
Joshua Mink
“Highly recommended! They excelled at regulatory projects, and document control, and grasped our product’s nuances quickly.”
Michal Depa
The Elexes Difference
Why Choose Elexes?
Manufacturers trust Elexes for disciplined, submission-focused regulatory execution.
Deep Expertise
50+ years of collective experience across FDA, ISO, and global medical device frameworks.
End-to-End
Support spans readiness, submission, approval, and post-market obligations without fragmented handoffs.
Proven Delivery
250+ successful projects across 200+ product types with a 90% audit clearance rate.
Flexible Support
Project-based, part-time, or embedded RAQA models help teams scale without adding headcount.
Meet The Elexes Team
Experienced regulatory specialists supporting complex device approvals.
Elexes Medical Consulting Pvt. Ltd. has built its reputation by helping medical device manufacturers navigate demanding regulatory pathways with precision and discipline. The company supports organizations across the product lifecycle, from early regulatory strategy and submission readiness through approvals, audits, and post-market obligations. With 50+ years of collective experience, the team brings cross-functional expertise in FDA submissions, quality systems, clinical documentation, and global market access. Elexes has completed 250+ successful projects across 200+ product types while supporting more than 100 global clients. Its approach centers on practical regulatory judgment, transparent execution, and documentation that can withstand scrutiny from authorities, auditors, and notified reviewers.
250+ ProjectsSuccessful regulatory and compliance engagements delivered.200+ Product TypesExperience across diverse medical device categories.90% Audit ClearanceStrong inspection and audit readiness outcomes.
Frequently Asked Questions
What is pre market approval for medical devices?
Premarket Approval, or PMA, is the FDA’s most rigorous review pathway for Class III medical devices. It requires valid scientific evidence demonstrating reasonable assurance of safety and effectiveness for the device’s intended use. A PMA typically includes clinical data, device description, manufacturing information, labeling, nonclinical testing, and detailed quality documentation reviewed under 21 CFR Part 814.
What are 21 CFR requirements?
21 CFR refers to Title 21 of the Code of Federal Regulations, which contains FDA regulations for products such as medical devices, drugs, and biologics. For device manufacturers, relevant parts often include Part 814 for PMA, Part 820 for quality systems, Part 803 for medical device reporting, and Part 801 for labeling. The exact requirements depend on device type and regulatory pathway.
Which devices require a PMA under 21 CFR Part 814?
PMA is generally required for Class III medical devices, especially those that support or sustain human life, are implanted, or present a potentially unreasonable risk of illness or injury. These devices usually cannot rely on substantial equivalence like a 510(k). FDA classification regulations, product codes, and prior agency feedback help determine whether PMA is the correct pathway.
What is included in a PMA submission?
A PMA submission typically includes administrative information, device description, indications for use, nonclinical testing, clinical investigation data when required, manufacturing methods and controls, labeling, summaries of safety and effectiveness, and supporting bibliographic references. FDA expects the submission to be internally consistent, scientifically justified, and traceable across technical, clinical, and quality documentation.
How is PMA different from a 510(k)?
A 510(k) is based on demonstrating substantial equivalence to a legally marketed predicate device, while a PMA requires independent evidence showing safety and effectiveness. PMA is more data-intensive, often involves clinical evidence, and receives deeper FDA review. It is typically used for higher-risk Class III devices, whereas many Class II devices follow the 510(k) pathway.
Can FDA issue deficiency questions during PMA review?
Yes. FDA commonly issues deficiency letters or additional information requests when sections are incomplete, inconsistent, or unsupported by adequate evidence. These questions may address clinical data, manufacturing controls, biocompatibility, software, labeling, or risk management. Well-prepared responses should directly answer each point, include supporting references, and maintain consistency across the full submission package.
How can a submission readiness assessment help before PMA filing?
A submission readiness assessment helps identify weaknesses before they become formal FDA deficiencies. It reviews whether technical documentation, clinical evidence, risk files, labeling, and quality system records are complete and aligned with the expected PMA standard. This allows manufacturers to prioritize remediation, improve submission quality, and avoid delays caused by preventable gaps or contradictory evidence.
Do PMA changes always require a supplement?
Not every change is handled the same way, but many significant changes to a PMA-approved device require FDA notification or a PMA supplement. The impact of changes to design, manufacturing, software, labeling, or intended use must be assessed carefully. A documented change impact assessment helps determine the appropriate regulatory action and creates an auditable rationale for the decision.
Still Have PMA Questions?
Talk with regulatory experts about your submission strategy and documentation gaps.
Certified & Trusted
Awards and Recognition
ISO 13485
Medical device quality systems expertise.
MDSAP
Multi-market audit readiness support.
IEC 62304
Software lifecycle compliance capability.
